Table 1.
Comparison of Blood Programs
| United States | Canada | France | UK | Australia | |
|---|---|---|---|---|---|
| Population⁎ | 307,212,123 | 33,487,208 | 64,420,073 | 61,113,205 | 21,262,641 |
| No. of blood establishments | >75 | 2 | 1 | 4 | 1 |
| Coordination challenge | High | Moderate | Low | Moderate | Low |
| No. of donations per year | 16,174,000 | 1,300,000 | 2,700,000 | 2,474,000 | 1,300,000 |
| Share blood products between providers | ✓ | ✓ | N/A | ✓ | N/A |
| Communication with other blood suppliers | Variable | ✓ | N/A | ✓ | N/A |
| Regulator | FDA | Health Canada | AFSSAPS | MHRA | ATGA |
| Standards | AABB | CSA | CoE | CoE | CoE |
| Funding | ARC, Blood systems some internal other initiatives, external |
Internal | I Internal |
Internal | Internal |
| Report transmissible disease to public health | ✓ | ✓ | ✓ | ✓ | ✓ |
Abbreviations: N/A, not applicable; AFSSAPS, Agence Française de Sécurité Sanitaire des Produits de Santé; MHRA, Medicines and Healthcare Products Regulatory Authority; ATGA, Australian Therapeutic Goods Administration; CSA, Canadian Standards Association; CoE, Council of Europe.